Company Overview

ARCpoint Inc. is a U.S.-based provider of clinical testing services operating primarily in the drug testing, alcohol screening, DNA testing, and clinical laboratory services industries. The company’s core business model centers on franchising and service delivery to employers, government agencies, legal professionals, and individuals requiring compliant and certified testing services. Its revenue is primarily driven by franchise fees, service fees from testing programs, and ancillary laboratory-related services.

The company is best known for operating under the ARCpoint Labs brand, which positions itself as a full-service provider of workplace compliance testing and personal diagnostics. ARCpoint Inc. emphasizes regulatory-compliant testing, rapid turnaround times, and a diversified menu of testing services as its primary competitive advantages. The company was founded in the late 2000s and evolved from a single testing operation into a franchised network, expanding its scope to meet growing employer demand for federally and state-mandated testing programs.

Business Operations

ARCpoint Inc. conducts its operations through its franchising and owned-location model, with ARCpoint Labs serving as the primary operating and revenue-generating business unit. Franchisees offer services including drug and alcohol testing, DNA testing, clinical blood work, and employer compliance programs. Revenue is generated through initial franchise fees, ongoing royalties, and testing services performed at corporate-owned or affiliated locations.

The company operates primarily within the United States, with limited international exposure. ARCpoint controls its proprietary operating systems, branding, and compliance frameworks but relies on third-party certified laboratories for certain testing analyses. Public disclosures reference subsidiaries associated with franchising and service operations; however, detailed segmentation beyond the core ARCpoint Labs business is limited, and data inconclusive based on available public sources regarding material joint ventures or international subsidiaries.

Strategic Position & Investments

Strategically, ARCpoint Inc. focuses on expanding its franchise footprint, increasing recurring revenue from employer compliance programs, and broadening its test offerings in response to evolving regulatory and workplace requirements. Growth initiatives have historically emphasized organic franchise development rather than large-scale acquisitions, with capital allocation constrained by its small-cap status.

The company has indicated interest in emerging areas such as expanded clinical diagnostics and personalized testing services, though public filings do not consistently disclose material investments in advanced laboratory technologies or biotechnology platforms. There is no verified evidence of significant acquisitions or controlling investments in unrelated sectors, and any references to expansion into new testing categories should be viewed as incremental rather than transformational.

Geographic Footprint

ARCpoint Inc. is headquartered in the United States and operates primarily across North America, with franchise and service locations distributed across multiple U.S. states. Its geographic reach is tied directly to franchise adoption and employer demand for compliance testing at the local and regional level.

The company does not report a significant operational presence outside the United States, and there is no verified disclosure of material international investment or foreign laboratory ownership. International influence, if any, appears limited to indirect testing partnerships rather than direct operational control.

Leadership & Governance

ARCpoint Inc. was founded by John Constantine, who has played a central role in shaping the company’s franchising strategy and service-oriented growth model. Leadership emphasizes disciplined expansion, regulatory compliance, and supporting franchise operators through standardized systems and centralized resources.

Key executives include:

• John Constantine – Chairman and Chief Executive Officer
• Stuart Hewitt – Chief Financial Officer
• Richard Ferris – President

Public disclosures provide limited detail on broader governance committees or independent board leadership, and data inconclusive based on available public sources regarding recent changes to executive composition or long-term succession planning.